Pharmacogenetics of Nucleoside Reverse-Transcriptase Inhibitor-Associated Peripheral Neuropathy
Asha Kallianpur(Cleveland Clinic Lerner College of Medicine), Todd Hulgan(Vanderbilt University Medical Center)
Cited by 45
Related Papers
New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis
|BMC Medicine|2020|458
Mitochondrial DNA G10398A Polymorphism and Invasive Breast Cancer in African-American Women
|Cancer Research|2005|259
A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19
|PLoS Biology|2020|186
Network medicine links SARS-CoV-2/COVID-19 infection to brain microvascular injury and neuroinflammation in dementia-like cognitive impairment
|Alzheimer s Research & Therapy|2021|167